ACE inhibitor and angiotensin-receptor blocker – A deadly combination
G. Sivagnanam1★★ Corresponding author
CORRESPONDENCE
G. Sivagnanam
Volume 2, Issue 4 · pp. 311–312 · PUBLISHED 2011 · DOI:
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
It is particular to note that ACE inhibitor/ARB combination therapy has been shown to offer no signifi cant clinical benefi ts over monotherapy, instead was associated with a worse safety and tolerability profi le. No morbidity and mortality data for direct renin inhibitor (DRI)/ACEI or DRI/ARB combinations are currently available
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sivagnanam, G. (2011). ACE inhibitor and angiotensin-receptor blocker – A deadly combination. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 311–312.
